Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity

Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…

EHA Presidential Interview: Konstanze Döhner

My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…

New Horizons in Chronic Lymphocytic Leukaemia : An Interview with Lydia Scarfò

This year, the EHA Congress provided us with long-term follow-up of some very interesting study, including the GAIA/CLL13 trial…

Physical Function Scores Help Predict Outcomes in Multiple Myeloma Treatment

A new study finds that how patients feel and function before starting treatment can help predict how well they’ll respond to multiple myeloma therapies.

New Genetic Score May Guide Leukaemia Treatment

A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment and address persistent racial disparities in outcomes.

EHA 2025 Interview: Martin Dreyling

EHA offers an incredible wealth of opportunities; it’s actually quite difficult to choose which highlights to include. We are fortunate to…

Scientists Discover Potent New Anticancer Compounds from Fungi

In a breakthrough that could lead to powerful new cancer treatments, researchers have identified a novel class of fungal compounds with potent anticancer properties.

Claudio Cerchione

Hema Now: Episode 21: Global Perspectives on Myeloma

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.

Loading posts...

« Previous 1 … 13 14 15 16 17 … 100 Next »